PMD
Psychemedics Corporation
NASDAQ · Healthcare
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | 21.4M | 24.9M | 25.2M | 22.1M | 19.7M |
| Cost of Revenue | 16.5M | 14.6M | 15.9M | 13.7M | 12.6M |
| Gross Profit | 4.9M | 10.3M | 9.3M | 8.4M | 7.1M |
| Operating Expenses | |||||
| R&D Expenses | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Total Op. Expenses | — | — | — | — | — |
| Operating Income | -6.1M | 209,000 | -1.1M | -2.9M | -1.9M |
| EBITDA | -2.4M | 4.9M | 2.2M | 256,000 | 193,000 |
| Below the Line | |||||
| Interest Expense | — | — | — | — | — |
| Pre-Tax Income | -6.2M | -821,000 | -1.0M | -3.4M | -1.9M |
| Income Tax | — | — | — | — | — |
| Net Income | -3.9M | -665,000 | -1.1M | -4.2M | -1.9M |
| Per Share | |||||
| EPS (basic) | $-0.70 | $-0.12 | $-0.19 | $-0.72 | — |
| EPS (diluted) | $-0.70 | $-0.12 | $-0.19 | $-0.72 | — |
| Shares | |||||
| Basic Shares | 6M | 6M | 6M | 6M | — |
| Diluted Shares | 6M | 6M | 6M | 6M | — |